搜索
,(,730000):;;:R395.1:A:1005-8559(2001)05-0507-02(QualityofLife,QOL),,,QOL,,QOL,[12](rheumatoidarthritis,RA),,,,,,QOL[34],,RAQOL[56](Ratingscale)QOL,,,(generalinstruments,)(disease-specificinstruments)[4,7],,QOL-C30[8];,,,(FunctionalLivingIndex-Cancer,FLIC)[9](ArthritisImpactMea-surementScale,AIMS),QOL[10]:(discriminative),;(evaluative),;,,,,;,;,RARAQOL,:RARA,,,,;,,,,,,,NSAIDs();(NSAIDs),,,,;(),,,RARA,[10]:ArthritisImpactMeasurementScale(AIMS)[9]EuroQOL[8,11]HealthAssessmentQuestionnaire(HAQ)[12]ModifiedHAQ(MHAQ)[12]McMaster-TorontoArthritis(MACTAR)PatientPref-erenceQuestionnaire[13]NottinghamHealthProfile(NHP)[14]SF-36[1516]LeeFunctionIndex,GastrointestinalSymptomRatingScale(GSRS),PsychologicalGeneralWell-BellingIndex(PGWBI)[10](),,,HAQ,,,24,3;,20[12]NHP38,,10[14]AIMS48,010,1520AIMS2AIMS,,20,,AIMSGERI-AIMS,RAAIMS18,,[9]SF-361136,,,14SF-367052001105,SF-36,,[1516],,[9],,1.RAHAQAIMS,,,(culturemodification),AIMS,[9,17],,2.RA,,,QOL,,RA,QOL,,,,,3.,,,,,,,,,RA()4.(breadth)(depth)[3,10],QOL,,-;,,,,5.(preference),,,,,[18][19][][1],.[J].,1998,19(8):400403.[2],.[J].,1995,2:4953.[3],,.[J].,1996,13(2):4952.[4],.[J].,1994,11(1):5457.[5],,,.[J].,1999,8(1):912.[6],,,.[J].,1999,3(3):169171.[7]DolanP.Valuinghealth-relatedqualityoflife[J].Pharmacoeco-nomics,1998,15(2):119127.[8],,,.-QOL-C30[J].,1998,17(3):237238.[9]MeenanRF,MasonJH,AndersonJJ,etal.AIMS2:thecontentandpropertiesofarevisedandexpandedarthritisimpactmeasure-mentscaleshealthstatusquestionnaire[J].ArthritisRheum,1992,35(1):110.[10]NicholMB,HaradaASM.Measuringtheeffectsofmedicationuseonhealth-relatedqualityoflifeinpatientswithrheumatoidarthri-tis[J].Pharmacoeconomics,1999,16(5Pt1):433448.[11]AaronsonNK,CullAM,KaasaS,etal.TheEuropeanOrganiza-tionforResearchandTreatmentofCancer(EORTC)modularap-proachtoqualityoflifeassessmentinoncology:anupdate[A].In:SpilkerB.Qualityoflifeandpharmacoeconomicsinclinicaltrial.SecondeditionLippincott-Ravenpublishers.Philadephia,1996.179189.[12],,.[J].,1990,5(5):193197.[13]ChamberLW.TheMcMasterHealthIndexQuestionnaire[A].In:SpilkerB.Qualityoflifeandpharmacoeconomicsinclinicaltrial.SecondeditionLippincott-Ravenpublishers.Philadephia,1996.267279.[14].[A].:...2.:,1998.163170.[15],,.SF-36[J].,1997,14(4):145147.[16],,.SF-36[J].,1999,8(2):150152.[17],.[J].,1994,74(3):175179.[18],,,.[J].,1999,8(4):234237.[19]KarlsonEW,KatzJN,LiangMH.Chronicrheumaticdisorders[A].In:SpilkerB.Qualityoflifeandpharmacoeconomicsinclinicaltrial.SecondeditionLippincott-Ravenpublishers.Philade-phia,1996.10291037.:(1969-),,,,:2001-02-13:805ChineseJournalofBehavioralMedicalScience10(5),2001